Intramuscular (IM) Injection Procedure
It is optimal for an intramuscular injection to have in possession syringes without the tips (needles) already affixed to them. Preferably, the individual should have the hermetically sealed syringes (barrels) separate from the hermetically sealed needle tips. Although one can easily use syringes with the tips already affixed, it is slightly more complicated and adds an extra step or two into the process that otherwise would not be there. So, every individual should ensure to the best of their ability to have the syringe and needle tips separate. The following is a list of required items for intramuscular injections :
The adverse effects of corticosteroids in pediatric patients are similar to those in adults (see ADVERSE REACTIONS ). Like adults, pediatric patients should be carefully observed with frequent measurements of blood pressure, weight, height, intraocular pressure, and clinical evaluation for the presence of infection, psychosocial disturbances, thromboembolism , peptic ulcers, cataracts, and osteoporosis. Pediatric patients who are treated with corticosteroids by any route, including systemically administered corticosteroids, may experience a decrease in their growth velocity. This negative impact of corticosteroids on growth has been observed at low systemic doses and in the absence of laboratory evidence of HPA axis suppression (ie, cosyntropin stimulation and basal cortisol plasma levels). Growth velocity may therefore be a more sensitive indicator of systemic corticosteroid exposure in pediatric patients than some commonly used tests of HPA axis function. The linear growth of pediatric patients treated with corticosteroids should be monitored, and the potential growth effects of prolonged treatment should be weighed against clinical benefits obtained and the availability of treatment alternatives. In order to minimize the potential growth effects of corticosteroids, pediatric patients should be titrated to the lowest effective dose.
The deltoid intramuscular injection site is the preferred site to administer vaccines for infants that are older than 7 months and this is the only site where the Hepatitis B vaccine can be given. The advantages of the deltoid intramuscular injection is that as said before is easy accessible and patients are generally a lot more comfortable with exposing their arms as opposed to another body area. Unlike the ventrogluteal injection, a tourniquet can be applied if a hypersensitivity reaction occurs after a deltoid intramuscular injection. Disadvantages to this site are the size of the muscle mass is small in relation to other IM injection sites. The deltoid intramuscular injection is closely associated with nerves and vascular structures; this leaves a small margin for error with departure from the correct IM injection site. A deltoid intramuscular injection is not an apt site for repeated or large-volume injections exceeding .